Clinical diagnosis of svPPA (as above) + ≥1 of: • Histopathologic evidence of a specific neurodegenerative pathology (e.g., FTLD-tau, FTLD-TDP, AD, other) • Presence of a known pathogenic mutation. This evidence concerns the gene MAPT and Alzheimer disease.